hepatic-steatosis

Documents about hepatic-steatosis

• Hepatic Steatosis After Cholecystectomy#806017ClinicalTrials.gov
• Attenuation Imaging in Hepatic Steatosis#908339ClinicalTrials.gov
• Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients#833811ClinicalTrials.gov
• Cholic Acid for Hepatic Steatosis in Lipodystrophy#812566ClinicalTrials.gov
• Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV#172541ClinicalTrials.gov
• Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic Steatosis#804706ClinicalTrials.gov
• Hepatic Steatosis and Chronic Hepatitis B Virus#915637ClinicalTrials.gov
• Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging#807426ClinicalTrials.gov
• The Relationship Between Long-term Oral Anti Hepatitis B Nucleoside Analogs and Hepatic Steatosis#813625ClinicalTrials.gov
• The Effect of a Probiotic on Hepatic Steatosis#152606ClinicalTrials.gov
• Influence of hepatic steatosis on antiseizure drug metabolism: in vitro evidence from differentiated HepaRG cells#159318HAL (France)
• Hepatic Mitochondrial Function in Youth#897832ClinicalTrials.gov
• Selenium and Liver Steatosis and Fibrosis: Opposing Direct and Steatosis-Mediated Associations in a Large Cohort#396643ODU Digital Commons
• Siemens Biomarker Multi-modality#858147ClinicalTrials.gov
• Post-Prandial Liver Glucose Metabolism in PCOS#353250ClinicalTrials.gov
• Effects of a Low Glycemic Load Diet on Fatty Liver in Children#125957ClinicalTrials.gov
• The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy#373758ClinicalTrials.gov
• Mitochondrial Metabolism and Hepatic Complications of Obesity#866661ClinicalTrials.gov
• A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis#874857ClinicalTrials.gov
• Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla#830550ClinicalTrials.gov
• Hepatic Steatosis Severity Prediction in Nonobese Individuals: Machine Learning Model Development and Validation.#298844NCBI PubMed Central
• Exploring the impacts of ketogenic diet on reversible hepatic steatosis: initial analysis in male mice#274353HAL (France)
• Impact of Elovl3 Suppression on Sleep Deprivation-Induced Hepatic Steatosis and Glucose Intolerance in Mice.#196091NCBI PubMed Central
• Automatic phenotyping of emergency department patients with incidental hepatic steatosis: A machine learning clustering analysis.#322977NCBI PubMed Central
• Gut microbiota composition combined with reduced intestinal fatty acid uptake prevents hepatic steatosis in obesity-resistant mice fed a high-fat diet#448737IBISS
• Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis#971090HAL (France)
• Elucidation of the effect of lauric acid on hepatic steatosis and insulin resistance in diet-induced obese mice#470893UTAR Institutional Repository
• Depletion of Liver Fat in Type 2 Diabetes#850997ClinicalTrials.gov
• Fatty Liver in Long Standing Cholecystectomy#995178ClinicalTrials.gov
• Polystyrene nanoplastics induce hepatic steatosis by disrupting autophagic degradation of NCoR1 and suppressing PPARα-mediated fatty acid oxidation.#186031NCBI PubMed Central
• Metabolic Changes in Healthy Subjects with Acute Binge Drink#970026ClinicalTrials.gov
• High daily fructose intake and late-evening fruit consumption are associated with ultrasonographically assessed hepatic steatosis in family medicine outpatients.#472367NCBI PubMed Central
• Health Effects of Biostimulated Lettuce in Human#824844ClinicalTrials.gov
• Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes#967608ClinicalTrials.gov
• Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening.#613519NCBI PubMed Central
• Longitudinal evaluation of hepatic and intestinal alterations and il8 expression in gabapentin-treated alcohol-exposed zebrafish: integration of experimental and bioinformatics analyses#673310ARPHA OAI-PMH Endpoint
• Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)#812991ClinicalTrials.gov
• Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)#369969ClinicalTrials.gov
• Mécanismes biologiques de la fonte lipidique à la cuisson et solutions nutritionnelles adaptées#330287HAL (France)
• A study of the protective effects of an aspalathin enriched green rooibos extract on experimentally induced hepatic steatosis#1024429UZSpace
• Nutritional and Behavioral Intervention for Long‐Term Childhood Acute Leukemia Survivors With Metabolic Syndrome#471957HAL (France)
• MRI to Measure Liver Fat Content#853432ClinicalTrials.gov
• Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients#895429ClinicalTrials.gov
• Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases#845154ClinicalTrials.gov
• Effect of a Low AGE Diet on Liver Function in Adults With Fatty Liver.#883936ClinicalTrials.gov
• Increased srum uric acid over five years is a risk factor for developing fatty liver#955297Koc University Digital Collections
• Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children#886395ClinicalTrials.gov
• Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink#993233ClinicalTrials.gov
• Pioglitazone to Treat Fatty Liver in People With HIV Infection#868834ClinicalTrials.gov
• Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: a transient elastography study#955524Koc University Digital Collections